ResearcherPhilipps University of MarburgActive in the last 2 years
Wouter H. de Vos tot Nederveen Cappel
Matched on ORCID iD 0000-0002-3956-1206; OpenAlex author ID A5051182160. Sources: OpenAlex.
Their work
- Papers
- 6 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2011: 1 paper · 2012: none · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: none · 2018: 1 paper · 2019: 1 paper · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 paper
Papers 6
- Pancreatic cancer risk and survival in patients with Lynch syndrome: a nationwide Dutch cohort study. Co-author DOI 10.1016/j.eclinm.2026.103755↗
- Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillanc… Co-author DOI 10.1016/j.hpb.2019.02.013↗
- High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers. Co-author DOI 10.1158/1940-6207.capr-18-0035↗
- Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Studies From Three European Expert Centers. Co-author DOI 10.1200/jco.2015.64.0730↗
- Variation in precursor lesions of pancreatic cancer among high-risk groups. Co-author DOI 10.1158/1078-0432.ccr-12-2730↗
- Magnetic resonance imaging surveillance detects early-stage pancreatic cancer in carriers of a p16-Leiden mutation. Last author DOI 10.1053/j.gastro.2010.11.048↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bert A. Bonsing · 5 shared papers, 2011–2019 · strength 0.26
- Paper Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a … DOI 10.1016/j.hpb.2019.02.013↗
- Paper High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers. DOI 10.1158/1940-6207.capr-18-0035↗
- Paper Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Stud… DOI 10.1200/jco.2015.64.0730↗
- Hans F. A. Vasen · 5 shared papers, 2011–2019 · strength 0.26
- Paper Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a … DOI 10.1016/j.hpb.2019.02.013↗
- Paper High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers. DOI 10.1158/1940-6207.capr-18-0035↗
- Paper Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Stud… DOI 10.1200/jco.2015.64.0730↗
- Martin N.J.M. Wasser · 5 shared papers, 2011–2019 · strength 0.26
- Paper Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a … DOI 10.1016/j.hpb.2019.02.013↗
- Paper High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers. DOI 10.1158/1940-6207.capr-18-0035↗
- Paper Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Stud… DOI 10.1200/jco.2015.64.0730↗
- Isaura S. Ibrahim · 3 shared papers, 2016–2019 · strength 0.21
- Paper Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a … DOI 10.1016/j.hpb.2019.02.013↗
- Paper High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers. DOI 10.1158/1940-6207.capr-18-0035↗
- Paper Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Stud… DOI 10.1200/jco.2015.64.0730↗
- Hans Morreau · 4 shared papers, 2011–2018 · strength 0.16
- Paper High Growth Rate of Pancreatic Ductal Adenocarcinoma in CDKN2A-p16-Leiden Mutation Carriers. DOI 10.1158/1940-6207.capr-18-0035↗
- Paper Benefit of Surveillance for Pancreatic Cancer in High-Risk Individuals: Outcome of Long-Term Prospective Follow-Up Stud… DOI 10.1200/jco.2015.64.0730↗
- Paper Variation in precursor lesions of pancreatic cancer among high-risk groups. DOI 10.1158/1078-0432.ccr-12-2730↗
- Bas Boekestijn · 1 shared paper, 2019 · strength 0.10
- Frederik Jan Hes · 2 shared papers, 2011–2018 · strength 0.09
- Nelleke A. Gruis · 2 shared papers, 2011–2018 · strength 0.09
- Rob A.E.M. Tollenaar · 2 shared papers, 2011–2018 · strength 0.09
- Thomas P. Potjer · 2 shared papers, 2013–2016 · strength 0.07
- Detlef Klaus Bartsch · 2 shared papers, 2013–2016 · strength 0.07
- Peter Langer · 2 shared papers, 2013–2016 · strength 0.07
- Emily P. Slater · 2 shared papers, 2013–2016 · strength 0.07
- Günter Klöppel · 2 shared papers, 2013–2016 · strength 0.07
- Evelina Mocci · 1 shared paper, 2016 · strength 0.04
- Enrique Vázquez-Sequeiros · 1 shared paper, 2016 · strength 0.04
- Volker Fendrich · 1 shared paper, 2016 · strength 0.04
- Iréne Esposito · 1 shared paper, 2016 · strength 0.04
- Alfredo Carrato · 1 shared paper, 2016 · strength 0.04
- Carmen Guillén‐Ponce · 1 shared paper, 2016 · strength 0.04
- Julie Earl · 1 shared paper, 2016 · strength 0.04
- Thomas Mathias Gress · 1 shared paper, 2013 · strength 0.03
- G. Johan A. Offerhaus · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.